← Eichor
Condition: Spinal Muscular Atrophy Type I Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Spinal Muscular Atrophy Type I

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Exploring Bulbar Function, Speech And Communication Development in SMA Type 1
Phase N/A · 1 location(s) · Institute of Child Health · NCT05954455
UK SMA Patient Registry
Phase N/A · 1 location(s) · Newcastle University · NCT04292574
Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy
NA · 4 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06562283
Study of Safety, Tolerability and Efficacy of GB221 in Infants With Spinal Muscular Atrophy Type 1
Phase 1/Phase 2 · 1 location(s) · Gemma Biotherapeutics · NCT07070999
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168
Test of Aquatic Mobility of SMA Infants
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06152302
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients
Phase 1/Phase 2 · 4 location(s) · GeneCradle Inc · NCT05824169
Assessing the Fertility Status of Men With Spinal Muscular Atrophy (SMA)
Phase N/A · 1 location(s) · Bar-Chama, Natan, M.D. · NCT06194539
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.